What are the Challenges Associated with Catalytic Inhibitors?
Despite their potential, catalytic inhibitors face several challenges:
Resistance - Cancer cells can develop resistance to inhibitors through mutations or activation of alternative pathways. Specificity - Achieving high specificity to target cancer cells while sparing normal cells to minimize side effects. Toxicity - Potential toxic effects on normal tissues and organs.
